Fundraising Fox
/People
Sign in

Marcos Milla

Investor

Venture Partner at Samsara BioCapital · Board director at Enlaza Therapeutics

San Diego, California

Writes $10M – $100M checks · typically $25M

Find your path to Marcos

449 people in our graph can introduce you to Marcos.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Jill Mooney to introduce you to Marcos

You →Jill · together at Synthorx Inc (2019–2021) →Marcos

Ask Jamie Chen to introduce you to Marcos

You →Jamie · together at Synthorx Inc →Marcos

Ask Sam Okafor to introduce you to Marcos

You →Sam · 8 people · together at Janssen, Pharmaceutical Companies of Johnson and Johnson →Marcos

Sign up to find every way you can get introduced to Marcos

  • Your email: the people you already email who know Marcos
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Marcos
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Venture Partner with expertise in drug discovery across autoimmunity, neuroscience, immuno-oncology, and orphan diseases. He was CSO of Synthorx through its acquisition by Sanofi and holds a PhD in Cell & Molecular Biology from Saint Louis University.

Board director at Enlaza Therapeutics

Intro paths

→

In turn, Marcos can intro founders to Enlaza Therapeutics's investors below.

Enlaza Therapeutics's investors · 8

Avalon BioVenturesLa Jolla · since 2025Frazier Life SciencesPalo Alto · since 2025J.P. Morgan Asset ManagementLightspeed Venture PartnersMenlo Park · $1M – $5M checksOrbiMedNew York · $1M – $75M checks · since 2025Pappas CapitalDurhamPfizer Venture Investments$5M – $20M checksSamsara BioCapitalMenlo Park · since 2025

Co-founders at Enlaza Therapeutics

SDSergio Duron
Sergio DuronCo-Founder & Chief Executive Officer
SMSanford Madigan
Sanford MadiganCo-Founder, President & Chief Business Officer

Experience

  1. Universidad Peruana Cayetano Heredia Board of PatronsMembercurrent2023 — presentLima, Peru
  2. Samsara BioCapitalVenture Partnercurrent2021 — presentGreater San Diego Area
  3. The Milla Goni Family FoundationPresidentcurrent2020 — presentSan Diego, California, United States
  4. Synthorx IncChief Scientific Officer2018 — 2021Greater San Diego Area
  5. Synthorx IncSenior Vice President of Research2017 — 2018Greater San Diego Area
  6. Adaptive Biotechnologies Corp.Vice President, Therapeutics2016 — 2017
  7. Janssen, Pharmaceutical Companies of Johnson and JohnsonGlobal Head, Emerging Science & Innovation, Discovery Sciences2014 — 2016La Jolla, CA, USA
  8. Janssen, Pharmaceutical Companies of Johnson and JohnsonScientific Director and Fellow, Immunology Discovery2009 — 2014La Jolla, California
  9. Roche PharmaceuticalsDirector2005 — 2009
  10. University of Pennsylvania School of MedicineProfessor1998 — 2005
  11. GlaxoSmithKlineResearch Investigator1995 — 1998
  12. MITPost Doctoral Fellow1990 — 1993

Skills & more

Protein Chemistry61Biotechnology44Biophysics38Biochemistry83Protein-protein Interactions8Biomarker Discovery10In Vitro25Signal Transduction27Medicinal Chemistry12Immunology34Molecular Biology56Oncology12
+12 moreDrug DiscoveryCellInflammationLifesciencesGPCRsAssay DevelopmentPharmacologyLife SciencesPharmaceutical IndustryCell CultureClinical DevelopmentDrug Development

Languages English · Spanish

From Marcos's professional profile.

Deals · 1

Lumen Bioscience, Inc.Board seat

via Samsara BioCapital · filed Apr 2025 · $23M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Per SEC Form D filings.

Colleagues at Samsara BioCapital

Abe Bassan
Principal at Samsara BioCapital
Alan Eisenberg
Venture Partner at Samsara BioCapital
Andrew Walker
Assistant Controller at Samsara BioCapital
Betsy Santos
Venture Partner, Chief People Officer at Samsara BioCapital
Carolyn Nguyen
Deputy General Counsel at Samsara BioCapital
Clara Dong
Senior Associate at Samsara BioCapital
Connie Su
Senior Fund Accountant at Samsara BioCapital
Cory Freedland
Investor at Samsara BioCapital

Network1

Abe Bassan
Principal at Samsara BioCapital

Investors connected to Marcos in public investor directories — a warm-intro map.

Frequently asked questions

Who is Marcos Milla?
Venture Partner with expertise in drug discovery across autoimmunity, neuroscience, immuno-oncology, and orphan diseases. He was CSO of Synthorx through its acquisition by Sanofi and holds a PhD in Cell & Molecular Biology from Saint Louis University.
Where does Marcos Milla work?
Marcos Milla is Venture Partner at Samsara BioCapital and Board director at Enlaza Therapeutics.
What check size does Marcos Milla write?
Marcos Milla typically writes checks of $10M – $100M.
What boards does Marcos Milla sit on?
Marcos Milla holds tracked board seats at Enlaza Therapeutics, Lumen Bioscience, Inc..
Where did Marcos Milla go to school?
Marcos Milla studied at Saint Louis University School of Medicine (PhD in Cell and Molecular Biology, Biochemistry and Molecular Biology); Duke University School of Medicine (Postdoc, Lipid biochemistry); Massachusetts Institute of Technology (JCCF Fellow, Protein chemistry and molecular genetics).

Same school

Also attended Universidad Peruana Cayetano Heredia1

Tony SalasChief Executive Officer at Shared-x

Shared employers